Viktor Von Wyl - Epidemiology

Author Information

Viktor Von Wyl is affiliated with the Epidemiology, Biostatistics & Prevention Institute at the University of Zurich, located at Hirschengraben 84, CH-8001, Zurich, Switzerland. His research primarily focuses on the epidemiology and public health impacts of various diseases, including COVID-19 and multiple sclerosis.

Research Contributions

Viktor Von Wyl has made significant contributions to the understanding of disease patterns and public health responses, particularly in the context of the COVID-19 pandemic. His work includes the development and evaluation of digital tools for disease monitoring and contact tracing, as well as studies on vaccination uptake and the use of disease-modifying therapies in multiple sclerosis. His research is instrumental in shaping public health policies and improving disease management strategies.

Aliases

Viktor Von Wyl is also known by the following aliases:

V Von Wyl V. Von Wyl Viktor Von Wyl

Publication and Citation Metrics

Metric	Value
Total Citation Count	5884
h-index	40
Total Paper Count	153

Publications:

The Corona Immunitas Digital Follow-Up eCohort to Monitor Impacts of the SARS-CoV-2 Pandemic in Switzerland: Study Protocol and First Results

DOI: 10.3389/ijph.2022.1604506

Year: 2022

Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland - a prospective cohort study.

DOI: 10.4414/smw.2022.w30162

Year: 2022

Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry.

DOI: 10.1016/j.msard.2022.103706

Year: 2022

Surgical procedures in inpatient versus outpatient settings and its potential impact on follow-up costs.

DOI: 10.1016/j.healthpol.2021.07.006

Year: 2021

Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?

DOI: 10.1016/j.jpsychores.2021.110402

Year: 2021

Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study

DOI: 10.1186/s12889-020-10079-8

Year: 2021

Backtracing persistent biomarker shifts to the age of onset: A novel procedure applied to men’s and women’s white blood cell counts in post-traumatic stress disorder

DOI: 10.1016/J.BIONPS.2021.100030

Year: 2021

The role of the SwissCovid digital contact tracing app during the pandemic response: results for the Canton of Zurich

DOI: 10.1101/2021.02.01.21250972

Year: 2021

Adherence and Association of Digital Proximity Tracing App Notifications With Earlier Time to Quarantine: Results From the Zurich SARS-CoV-2 Cohort Study

DOI: 10.3389/ijph.2021.1603992

Year: 2021

Use of Venn Diagrams to Evaluate Digital Contact Tracing: Results from a Panel Survey Analysis (Preprint)

DOI: 10.2196/preprints.30004

Year: 2021

What Technologies Are Commonly Used in Epidemiology?

How Do Epidemiologists Evaluate Medication Effectiveness?

What is Antimicrobial Stewardship?

What Types of Information Do These Reports Contain?

What Strategies Can Be Used to Address Network Vulnerabilities?

What are the Key Comorbidities Included?

How Do Vectors Contribute to Disease Transmission?

What are the Challenges in Using PROs?

What are the Socio-economic Determinants?

What are Social Sciences?

Partnered Content Networks

Relevant Topics